RUO‘ZENLog in
Stocks › Healthcare › EXEL

Exelixis stockEXEL

Exelixis Inc · Nasdaq
$68.71
−5.55% on the day
close Nov 5, 2026
What is happening with the stock

Exelixis trades at $68.71, 6.8% below its 52-week high (Nov 5, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +56.8% year to date, +70.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 9, 2027.

Closing price, 6 monthsdetailed chart in the terminal
47.2060.8174.4352-week high 73.69May 8, 2026Nov 5, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for EXEL — after you log in

Open the terminal
From 52-week high−6.8%
High73.69 Nov 5, 2026
vs 50-day avg+13.3%
vs 200-day avg+33.6%
Year to date+56.8%
12 months+70.2%
P/E18.8
Dividend yieldnone
EarningsFeb 9
Market cap$16.8B
Chart patternflat base
Exchange · sinceNasdaq · 2000

Frequently asked questions about Exelixis

What is the Exelixis stock price?

At the close on Nov 5, 2026: $68.71 (−5.55% on the day). 52-week high: $73.69 on Nov 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Exelixis report earnings?

The next quarterly report is on Feb 9, 2027. Last quarter, earnings per share changed +21% year over year, revenue +10%.

Does Exelixis pay dividends?

No, Exelixis does not pay dividends.

Where does Exelixis trade and how to buy it?

Ticker EXEL, exchange Nasdaq, listed since 2000. You can buy it through a broker with access to US exchanges.

Should I buy Exelixis now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for EXEL are in the terminal after you log in.

Similar stocks

More on EXEL

Included in lists